These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 22853433)

  • 1. The effects of low-dose nepsilon-(carboxymethyl)lysine (CML) and nepsilon-(carboxyethyl)lysine (CEL), two main glycation free adducts considered as potential uremic toxins, on endothelial progenitor cell function.
    Zhu J; Yang K; Jing Y; Du R; Zhu Z; Lu L; Zhang R
    Cardiovasc Diabetol; 2012 Aug; 11():90. PubMed ID: 22853433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous Determination of N
    Gong RZ; Wang YH; Wang YF; Chen B; Gao K; Sun YS
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30558131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of Nepsilon-(carboxymethyl)lysine and Nepsilon-(carboxyethyl)lysine in human plasma protein by stable-isotope-dilution tandem mass spectrometry.
    Teerlink T; Barto R; Ten Brink HJ; Schalkwijk CG
    Clin Chem; 2004 Jul; 50(7):1222-8. PubMed ID: 15131022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of inhibitor compounds on Nε-(carboxymethyl)lysine (CML) and Nε-(carboxyethyl)lysine (CEL) formation in model foods.
    Srey C; Hull GL; Connolly L; Elliott CT; del Castillo MD; Ames JM
    J Agric Food Chem; 2010 Nov; 58(22):12036-41. PubMed ID: 21043504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment the influence of salt and polyphosphate on protein oxidation and Nε-(carboxymethyl)lysine and Nε-(carboxyethyl)lysine formation in roasted beef patties.
    Li Y; Xue C; Quan W; Qin F; Wang Z; He Z; Zeng M; Chen J
    Meat Sci; 2021 Jul; 177():108489. PubMed ID: 33714683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: correlation with markers of endothelial dysfunction.
    Lieuw-A-Fa ML; van Hinsbergh VW; Teerlink T; Barto R; Twisk J; Stehouwer CD; Schalkwijk CG
    Nephrol Dial Transplant; 2004 Mar; 19(3):631-6. PubMed ID: 14767019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.
    van de Kerkhof J; Schalkwijk CG; Konings CJ; Cheriex EC; van der Sande FM; Scheffer PG; ter Wee PM; Leunissen KM; Kooman JP
    Nephrol Dial Transplant; 2004 Apr; 19(4):910-6. PubMed ID: 15031349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of bicarbonate/lactate-buffered PD fluids on N{ε}-(carboxyethyl)lysine and N{ε}-(carboxymethyl)lysine in peritoneal effluent.
    Cnossen TT; Gladziwa U; van de Kerkhof JJ; Schalkwijk CG; Scheijen J; van Amersfoort J; Moret K; Beerenhout CH; Kooman JP
    Perit Dial Int; 2011; 31(2):189-93. PubMed ID: 20671103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products.
    Liang C; Ren Y; Tan H; He Z; Jiang Q; Wu J; Zhen Y; Fan M; Wu Z
    Br J Pharmacol; 2009 Dec; 158(8):1865-73. PubMed ID: 19917066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress.
    Chen J; Song M; Yu S; Gao P; Yu Y; Wang H; Huang L
    Mol Cell Biochem; 2010 Feb; 335(1-2):137-46. PubMed ID: 19756958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells.
    Li H; Zhang X; Guan X; Cui X; Wang Y; Chu H; Cheng M
    Cardiovasc Diabetol; 2012 Apr; 11():46. PubMed ID: 22545734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
    Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
    Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody.
    Koito W; Araki T; Horiuchi S; Nagai R
    J Biochem; 2004 Dec; 136(6):831-7. PubMed ID: 15671494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of Nε-(carboxyethyl) lysine in Caenorhabditis elegans is correlated with the formation of ketone body.
    Sugawa H; Yachi A; Fujimoto Y; Nagai R
    J Biochem; 2021 Dec; 170(5):587-592. PubMed ID: 34213548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous analysis of N(ε) -(carboxymethyl)Lysine and N(ε) -(carboxyethyl)lysine in foods by ultra-performance liquid chromatography-mass spectrometry with derivatization by 9-fluorenylmethyl chloroformate.
    Zhou Y; Lin Q; Jin C; Cheng L; Zheng X; Dai M; Zhang Y
    J Food Sci; 2015 Feb; 80(2):C207-17. PubMed ID: 25559609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil-derived advanced glycation end products-Nε-(carboxymethyl) lysine promotes RIP3-mediated myocardial necroptosis via RAGE and exacerbates myocardial ischemia/reperfusion injury.
    Yang J; Zhang F; Shi H; Gao Y; Dong Z; Ma L; Sun X; Li X; Chang S; Wang Z; Qu Y; Li H; Hu K; Sun A; Ge J
    FASEB J; 2019 Dec; 33(12):14410-14422. PubMed ID: 31665609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N
    Yu L; Li Y; Gao C; Yang Y; Zeng M; Chen J
    Food Res Int; 2022 May; 155():111048. PubMed ID: 35400433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-bound uraemic toxins, dicarbonyl stress and advanced glycation end products in conventional and extended haemodialysis and haemodiafiltration.
    Cornelis T; Eloot S; Vanholder R; Glorieux G; van der Sande FM; Scheijen JL; Leunissen KM; Kooman JP; Schalkwijk CG
    Nephrol Dial Transplant; 2015 Aug; 30(8):1395-402. PubMed ID: 25862762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study.
    Scheijen JLJM; Hanssen NMJ; van Greevenbroek MM; Van der Kallen CJ; Feskens EJM; Stehouwer CDA; Schalkwijk CG
    Clin Nutr; 2018 Jun; 37(3):919-925. PubMed ID: 29381139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of advanced glycation endproducts Nε-(carboxymethyl)lysine, Nε-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the Hoorn and CODAM studies.
    Hanssen NM; Engelen L; Ferreira I; Scheijen JL; Huijberts MS; van Greevenbroek MM; van der Kallen CJ; Dekker JM; Nijpels G; Stehouwer CD; Schalkwijk CG
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1369-73. PubMed ID: 23780372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.